Cited by 209Genital Health and DiseaseHIV/AIDS Research and InterventionsMale Reproductive Health Studies

The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study.

Open access
Gray, Ron, Kigozi, Godfrey, Kong, Xiangrong, Ssempiija, Victor, Makumbi, Frederick, Wattya, Stephen, Serwadda, David, Nalugoda, Fred +2 more·2012·AIDS

Abstract

BACKGROUND: The efficacy of male circumcision for HIV prevention over 2 years has been demonstrated in three randomized trials, but the longer-term effectiveness of male circumcision is unknown. METHODS: We conducted a randomized trial of male circumcision in 4996 HIV-negative men aged 15-49 in Rakai, Uganda. Following trial closure, we offered male circumcision to control participants and have maintained surveillance for up to 4.79 years. HIV incidence per 100 person-years was assessed in an as-treated analysis, and the effectiveness of male circumcision was estimated using Cox regression models, adjusted for sociodemographic and time-dependent sexual behaviors. For men uncircumcised at trial closure, sexual risk behaviors at the last trial and first posttrial visits were assessed by subsequent circumcision acceptance to detect behavioral risk compensation. RESULTS: By 15 December 2010, 78.4% of uncircumcised trial participants accepted male circumcision following trial closure. During posttrial surveillance, overall HIV incidence was 0.50/100 person-years in circumcised men and 1.93/100 person-years in uncircumcised men {adjusted effectiveness 73% [95% confidence interval (CI) 55-84%]}. In control arm participants, posttrial HIV incidence was 0.54/100 person-years in circumcised and 1.71/100 person-years in uncircumcised men [adjusted effectiveness 67% (95% CI 38-83%)]. There were no significant differences in sociodemographic characteristics and sexual behaviors between controls accepting male circumcision and those remaining uncircumcised. CONCLUSION: High effectiveness of male circumcision for HIV prevention was maintained for almost 5 years following trial closure. There was no self-selection or evidence of behavioral risk compensation associated with posttrial male circumcision acceptance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e3283504a3f

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Follow-up studies have demonstrated sustained benefit of circumcision for HIV prevention.

    “Follow-up studies have demonstrated sustained benefit of circumcision for HIV prevention (69) and that the effect is not mediated solely through a reduction in HSV-2 infection or genital ulcer disease (GUD) (70).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [69]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gray, R., Kigozi, G., Kong, X., Ssempiija, V., Makumbi, F., Wattya, S., Serwadda, D., Nalugoda, F., Sewenkambo, N. K., & Wawer, M. J.
Affiliations
Johns Hopkins University (US)
Corresponding author
Gray, Ron
Venue
AIDS
Published
2012-03-13
Volume
26
Issue
5
Pages
609-615
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2037087763
Cited by
209
References
11
Citations by year
2025: 1 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 15 · 2016: 44 · 2015: 23 · 2014: 20 · 2013: 37 · 2012: 13
FWCI
23.22
Type
journal article
Language
en
Open access
Locations
  • AIDS (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (U1AI51171, U01AI051171, U01AI075115)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042854)
Topics
  • Health Sciences › Medicine › Surgery › Genital Health and Disease
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Health Professions › General Health Professions › Male Reproductive Health Studies
Keywords
male circumcision, HIV prevention, HIV incidence, long-term effectiveness, risk compensation, sexual risk behavior, Rakai, Uganda, HIV-negative men
MeSH terms
Adolescent, Adult, Circumcision, Male, Follow-Up Studies, Humans, Male, Middle Aged, Risk-Taking, Sexual Behavior, Uganda, HIV Infections, Incidence, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review